"Advanced treatment for medication resistant depression which includes Transcranial Magnetic Stimulation (TMS), esKetamine and Ketamine treatments."

During the past decade, Kadima Neuropsychiatry conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kadima Neuropsychiatry" are "Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment" (1 trials) and "Post-Traumatic Stress Disorder" (1 trials). Many other conditions were trialed in "Kadima Neuropsychiatry" in a lesser frequency.

Most popular intervention types in "Kadima Neuropsychiatry" are "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "CBT-based, mobile-delivered, intervention platform" (1 trials), "Deep TMS System" (1 trials) and "Sham Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kadima Neuropsychiatry" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kadima Neuropsychiatry". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kadima Neuropsychiatry, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kadima Neuropsychiatry, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".